Galectin Therapeutics Inc. Common Stock — Institutional Ownership
Which tracked institutions hold GALT, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
14
Funds holding
$5041035
Total value held
Buying
9 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $2229871 | 799237 | +2679 | +0.34% |
| 2 | State Street Corp | $721025 | 258432 | +16200 | +6.69% |
| 3 | Goldman Sachs Group Inc | $515416 | 184737 | -122492 | -39.87% |
| 4 | Northern Trust Corp | $363950 | 130448 | — | Held |
| 5 | Barclays Plc | $312056 | 111848 | — | NEW BUY |
| 6 | Morgan Stanley | $291290 | 104405 | -174883 | -62.62% |
| 7 | Truist Financial Corp | $189720 | 68000 | — | Held |
| 8 | Bank Of America Corp /De/ | $150275 | 53862 | +28799 | +114.91% |
| 9 | Pinnacle Financial Partners, Inc. | $116204 | 41650 | — | NEW BUY |
| 10 | Citigroup Inc | $46696 | 11225 | +11089 | +8153.68% |
| 11 | Invesco Ltd. | $42756 | 10278 | — | NEW BUY |
| 12 | Raymond James Financial Inc | $41758 | 14967 | +1250 | +9.11% |
| 13 | Wells Fargo & Company/Mn | $17018 | 4091 | — | Held |
| 14 | Royal Bank Of Canada | $3000 | 1067 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.